Isolated optic neuritis and its prognosis for multiple sclerosis: A clinical and paraclinical study with evoked potentials. CSF examination and brain MRI

Italian Journal of Neurological Sciences

Volumn 17, Issue 5, 1996, Pages 325-332

  Ghezzi, A ^a   Torri, V ^b   Zaffaroni, M ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c Centre Studi Sclerosi Multipla   (Italy)

Author keywords

Brain mri; Evoked potentials; Intrathecal igg synthesis; Multiple sclerosis; Optic neuritis

Indexed keywords

IMMUNOGLOBULIN G;

ADULT; ARTICLE; BRAIN; CEREBROSPINAL FLUID; DISEASE COURSE; EVOKED RESPONSE; FEMALE; FOLLOW UP; HUMAN; LIFE TABLE; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; OPTIC NEURITIS; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; PROGNOSIS; RECURRENT DISEASE; RISK FACTOR;

ADULT; AGE OF ONSET; BRAIN; DISEASE PROGRESSION; EVOKED POTENTIALS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN G; LIFE TABLES; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; OPTIC NEURITIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECURRENCE; RISK FACTORS;

EID: 0030254907     PISSN: 03920461     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01999894     Document Type: Article

References (66)

1. ALTER M., GOOD J., OKIHIRO M.: Optic neuritis in Orientals and Caucasians. Neurology 23: 631-639, 1973,
2. BECK R.W., CLEARY P.A., ANDERSON M.M., et al.: A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. New Engl. J. Med. 326: 581-588, 1992.
3. BECK R.W., CLEARY P.A., TROBE J.D. et al.: The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. N. Engl. J. Med. 329: 1764-1769, 1993.
4. BRADLEY W.G., WHITTY C.W.M.: Acute optic neuritis: prognosis for development of multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 31: 10-18, 1968.
5. COHEN M.M., LESSELL S., WOLF P.A.: A prospective study of the risk of developing multiple sclerosis in un-complicated optic neuritis. Neurology 29: 208-213, 1979.
6. COLLIS W.J.: Acute unilateral retrobulbar neuritis. Arch. Neurol. 13: 409-412, 1965.
7. COMPSTON D.A.S., BATCHELOR J.R., EARL C.J., McDoNALD W.I.: Factors influencing the risk of multiple sclerosis developing in patients with optic neuritis. Brain 101: 495-511, 1978.
8. CORRIDORI F., SALMAGGI A., BARTOLAMI C. et al.: Prognostic value of cerebrospinal fluid electrophoresis in optic neuritis and suspected multiple sclerosis. Ital. J. Neurol. Sei. (Suppl. 6): 77-80, 1987.
9. EBERS G.C.: Optic neuritis and multiple sclerosis. Arch. Neurol. 42: 702-704, 1985.
10. ERSMARK B., SIDEN A.: Isoelectric focusing of CSF proteins and the future evolution of multiple sclerosis: a clinical follow-up. J. Neurol. 231: 117-121, 1984.
11. FEASBY T.E., EBERGS G.G.: Risk of multiple sclerosis in isolated optic neuritis. J. Canadian Sei. Neurol. 9: 26, 1982.
12. FILIPPI M., HORSFIELD M.A., MORRISSEY S.P., et al.: Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis. Neurology 44: 635-641, 1994.
13. FILIPPINI G., COMI G., Cosi, V. et al.: Sensitivities and predictive values of paraclinical tests for diagnosing multiple sclerosis. J. Neurol. 241: 132-137, 1991.
14. FRANCIS D.A., COMPSTON D.A.S., BATCHELOR J.R., McDoNALD W.I.: A reassessment of the risk of multiple sclerosis developing in patients with optic neuritis after extend follow-up. J. Neurol. Neurosurg. Psychiatry. 50: 758-765, 1987.
15. FREDERIKSEN J.L., LARSSON H.B.W., HENRIKSEN O., OLESEN J.: Magnetic resonance imaging of the brain in patients with acute monosymptomatic optic neuritis. Acta Neurol. Scand. 80: 512-517, 1989.
16. FREDERIKSEN J.L., LARSSON H.B.W., OLESEN J., STIGSBY B.: MRI, VEP, SEP and biothensiometry suggest monosymptomatic acute optic neuritis to be a first manifestation of multiple sclerosis. Acta Neurol. Scand. 83: 343-350, 1991.
17. GHEZZI A., CAPUTO D., MARFORIO S.: Evoluzione e prognosi délia névrite ottica retrobulbare come sintomo iniziale di sclerosi multipla. Minerva Medica 70: 37973801, 1979.
18. GHEZZI A., ZAFFARONI M., CAPUTO D. et al.: Evaluation of evoked potentials and lymphocyte subsets as possible markers of MS: one-year follow-up of 30 patients. J. Neurol. Neurosurg. Psychiatry. 49: 913-919, 1986.
19. GHEZZI A., CALLEA L., ZAFFARONI M., MONTANINI R.: Study of central and peripheral motor conduction in normal subjects. Acta Neurol. Scand. 84: 503-506, 1991.
20. HELY M.A., Me MAINS P.G., DORAN T.J. et al.: Acute optic neuritis: a prospective study of risk factors for multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 49: 11251130, 1986.
21. HUTCHINSON W.M.: Acute optic neuritis and the prognosis for multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 39: 283-289, 1976.
22. JACOBS L., KINKEL P.R., KINKEL W.R.: Silent brain lesions in patients with isolated idiopathic optic neuritis. Arch. Neurol. 43: 452-455, 1986.
23. JACOBS L., MUNSCHAUER F.E., KABA S.E.: Clinical and magnetic resonance imaging in optic neuritis. Neurology 41: 15-19, 1991.
24. JOHNS K., LAVIN P., ELLIOT J.H., PARTIAN L.: Magnetic resonance imaging of the brain in isolated optic neuritis. Arch. Ophthalmol. 104: 1486-1488, 1986.
25. JOHNSON K.P., BROOKS B.R., COHEN J.A. et al.: Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis. Neurology 45: 1268-1276, 1995.
26. KAHANA E., ALTER M., FELDMAN S.: Optic neuritis in relation to multiple sclerosis. J. Neurol. 213: 87-95, 1976.
27. KINNUNEN E., LARSEN A., KETONEN L. et al.: Evaluation of central nervous system involvement in uncomplicated optic neuritis after prolonged follow-up. Acta Neurol. Scand. 76: 147-151, 1987.
28. KURLAND L.T., BEEBE G.W., KURTZKE J.F., et al.: Studies on the natural history of multiple sclerosis. II. The progression of optic neuritis to multiple sclerosis. Acta Neurol. Scand. 42 (suppl. 19): 157-176, 1966.
29. KURTZKE J.F.: Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 83: 1444-1452, 1983.
30. KURTZKE J.F.: Optic neuritis or multiple sclerosis. Arch. Neurol. 42: 704-710, 1985.
31. LANDY P.J.: A prospective study of the risk of developing multiple sclerosis in optic neuritis in a tropical and subtropical area. J, Neurol. Neurosurg. Psychiatry 46: 659661, 1983.
32. LEE K.H., HASHIMOTO S.A., HOODOE J.P. et al.: Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis. Neurology 41: 657-660, 1991.
33. LINK H.: Comparison of electrophoresis on agar gel and agarose gel in the evaluation of gamma-globulin abnormalities in cerebrospinal fluid and serum in multiple sclerosis. Clin. Chem. Acta 46: 383-389, 1973.
34. MAPELLI G., PAVONI M., DE PALMA P. et al.: Progression of optic neuritis to multiple sclerosis: a prospective study in an Italian population. Neuroepidemiology 10: 117-121, 1991.
35. MARTINELLI V., COMI G., FILIPPI M. et al.: Paraclinical tests in acute-onset optic neuritis: basal data and results of a short follow-up. Acta Neurol. Scand. 84: 231-237, 1991.
36. Me ALPINE D.: The benign form of multiple sclerosis. Br. Med. J. 2: 1029-1032, 1964.
37. MILLER D.H., ORMEROD I.E.C., Me DONALD W.I. et al.: The early risk of multiple sclerosis after optic neuritis. J. Neurol. Neurosurg. Psychiatry 51: 1569-1571, 1988.
38. MORRISSEY S.P., MILLER D.H., KENDALL B.E. et al.: The .significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. Brain 116: 135146, 1993.
39. MOULIN D., PATY D.W., EBERS G.C.: The predictive value of cerebrospinal fluid electrophoresis in possible multiple sclerosis. Brain 106: 809-816, 1983.
40. NIKOSKELAINEN E., ÜRJALA K., SALMI T.T.: Cerebrospinal fluid findings in patients with optic neuritis. Acta Ophthalmol. 53: 105-119, 1975.
41. NIKOSKELAINEN E., FREY H., SALMI A.: Prognosis of optic neuritis with special reference to cerebrospinal fluid immunoglobulins and measles virus antibodies. Ann. Neurol. 9: 545-550, 1981.
42. OLSSON T., KOSTULAS V., LINK H.: Improved detection of oligoclonal IgG in cerebrospinal fluid by agarose isoelectric focusing, double-antibody peroxidase and avidin-biotin amplification. Clin. Chem. 30: 1246-1249, 1984.
43. ORMEROD I.E.G., MCöONALD W.I., DOBOULAY G.H. et al.: Disseminated lesions at presentation in patients with optic neuritis. J. Neurol. Neurosurg. Psychiatry 49: 124127, 1986.
44. ORMEROD I.E.G., MILLER D.H., MCDONALD W.I. et al.: The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study. Brain 110: 1579-1616, 1987.
45. PATY D.W., OGER J.J.F., KASTUKOFF L.F. et al.: MR1 in the diagnosis of MS: a prospective studv with comparison of clinical evaluation, evoked potentials, oligoclonal banding and CT. Neurology 38: 180-185, 1988.
46. PERCY A., NOBREGA F., KURLAND L.: Optic neuritis and multiple sclerosis. Arch. Ophthalmol. 87: 135-139, 1972.
47. PERKIN G.D., ROSE F.C.: Optic neuritis and its differential diagnosis. Oxford. England, Oxford University Press, 1979.
48. POSER C.M., PATY D.W., SCHEINBERG L. et al.: New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13: 227-231, 1983.
49. Rizzo J.F., LESSELL S.: Risk of developing multiple sclerosis after uncomplicated optic neuritis: a long-term prospective study. Neurology 38: 185-190, 1988.
50. RoDRiGUEzM., SIVA A., CROSS S.A. et al.: Optic neuritis: a population-based study in Olmsted County, Minnesota. Neurology 45: 244-250, 1995.
51. RUDIK R.A., JACOBS L., KINKEL P.R., KINKEL W.R.: Isolated idiopathic optic neuritis. Analysis of free K-light chains in cerebrospinal fluid and correlation with nuclear magnetic resonance findings. Arch. Neurol. 43: 456458, 1986.
52. RUNMARKER N., ANDERSEN O.: Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up. Brain 116: 117-134, 1993.
53. SANDBERG-WOLLHEIM M.: Optic neuritis: studies on the cerebrospinal fluid in relation to clinical course in 61 patients. Acta Neurol. Scand. 49: 443-452, 1975.
54. SANDBERG-WOLLHEIM M., BYNKE H., CRONQUIST S., et al.: A long-term prospective study of optic neuritis: evaluation of risk factors. Ann. Neurol. 27: 386-393, 1990.
55. SANDERS E.A.C.M., REULEN J.P.H., HOGENHUIS L.A.H.: Central nervous system involvement in optic neuritis. J. Neurol. Neurosurg. Psychiatry 47: 241-249, 1984.
56. SANDERS E.A.C.M., BOLLEN E.L.E.M., VAN DER VELDE E.A.: Presenting signs and symptoms in multiple sclerosis. Acta Neurol. Scand. 73: 269-272, 1986.
57. SCHMIDT R.M., KUPPE G., KISSING B. et al.: Research approaches on the diagnosis of multiple sclerosis by CSF examination. Arch. Suisses Neurol. Psychiat. 38: 13-22, 1987.
58. SODERSTROM M., LiNDQUiST M., HiLLERT J. et al.: Opticneuritis: findings on MRI, CSF examination and HLA class II typing in 60 patients and results of a short-term follow-up. I. Neurol. 241: 391-397, 1994.
59. SOLA P., MERELLI E., SCHOENHUBER R. et al.: Neurophysiological and CSF immunological study of 19 patients affected by acute idiopathic optic neuritis. Acta Neurol. Scand. 75: 140-144, 1987.
60. STAEDT D., KAPPOS L., ROHRBACK E., HEUN R.: Contributions of magnetic resonance imaging to the diagnosis of MS in isolated optic neuritis. Psychiatry Research 29: 295-296, 1989.
61. STENDAHL BRODIN L., LINK H.: Optic neuritis: oligoclonal bands increase the risk of multiple sclerosis. Acta Neurol. Scand. 67: 301-304, 1983.
62. TACKMANN W., ETTLIN T., STRENGE H.: Multimodality evoked potentials and electrically elicited blink reflex in optic neuritis. J. Neurol. 227 (3): 157-163, 1982.
63. THE IFNB MULTIPLE SCLEROSIS STUDY GROUP: Interferon beta-lb is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43: 655661, 1993.
64. TIBBLINO G., LINK H., OHMAN S.: Principles of albumin and IgG analyses in neurological disorders: I. Establishment of reference values. Scand. J. Clin. Lab. Invest. 37: 385-390, 1977.
65. WEINSHENKER E.G., BASS B., RICE O.P.A. et al.: The natural history of multiple sclerosis. Part 3. Brain 112: 133-146, 1989.
66. WEINTRAUB M.I.: Optic neuritis and MS. (Letter). Neurology 38: 1660-1661, 1988.